Jasper Hellweg
Stock Analyst at Argus Research
(2.10)
# 2,838
Out of 5,182 analysts
92
Total ratings
47.22%
Success rate
3.41%
Average return
Main Sectors:
Stocks Rated by Jasper Hellweg
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMGN Amgen | Maintains: Buy | $360 → $400 | $349.82 | +14.34% | 1 | Feb 6, 2026 | |
| BAX Baxter International | Downgrades: Hold | n/a | $17.63 | - | 3 | Oct 31, 2025 | |
| ZTS Zoetis | Reiterates: Buy | $190 | $120.08 | +58.23% | 7 | Sep 9, 2025 | |
| BIIB Biogen | Downgrades: Hold | n/a | $176.37 | - | 4 | Apr 4, 2025 | |
| UTHR United Therapeutics | Maintains: Buy | $360 → $400 | $577.63 | -30.75% | 7 | Oct 31, 2024 | |
| ILMN Illumina | Upgrades: Buy | $150 | $126.96 | +18.15% | 7 | Aug 28, 2024 | |
| SNY Sanofi | Maintains: Buy | $55 → $60 | $46.96 | +27.77% | 2 | Jul 26, 2024 | |
| REGN Regeneron Pharmaceuticals | Maintains: Buy | $1,060 → $1,170 | $746.46 | +56.74% | 9 | Jun 25, 2024 | |
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $465 → $550 | $440.05 | +24.99% | 7 | Jun 17, 2024 | |
| AZN AstraZeneca | Maintains: Buy | $80 → $85 | $202.24 | -57.97% | 3 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $125 | $37.98 | +229.12% | 1 | Feb 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $160 → $140 | $50.68 | +176.24% | 4 | Sep 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $206.47 | - | 2 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $31.15 | - | 1 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $260 → $290 | $171.99 | +68.61% | 4 | Sep 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $100 | $87.73 | +13.99% | 3 | Jun 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $270 → $295 | $264.18 | +11.67% | 4 | May 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $8.24 | - | 3 | May 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $135 | $192.91 | -30.02% | 5 | Oct 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $11.31 | - | 2 | Apr 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $186.47 | - | 3 | Apr 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $213.44 | - | 2 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $29.19 | - | 4 | Oct 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $155 | $497.42 | -68.84% | 3 | Nov 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $90 | $58.79 | +53.09% | 1 | Sep 19, 2018 |
Amgen
Feb 6, 2026
Maintains: Buy
Price Target: $360 → $400
Current: $349.82
Upside: +14.34%
Baxter International
Oct 31, 2025
Downgrades: Hold
Price Target: n/a
Current: $17.63
Upside: -
Zoetis
Sep 9, 2025
Reiterates: Buy
Price Target: $190
Current: $120.08
Upside: +58.23%
Biogen
Apr 4, 2025
Downgrades: Hold
Price Target: n/a
Current: $176.37
Upside: -
United Therapeutics
Oct 31, 2024
Maintains: Buy
Price Target: $360 → $400
Current: $577.63
Upside: -30.75%
Illumina
Aug 28, 2024
Upgrades: Buy
Price Target: $150
Current: $126.96
Upside: +18.15%
Sanofi
Jul 26, 2024
Maintains: Buy
Price Target: $55 → $60
Current: $46.96
Upside: +27.77%
Regeneron Pharmaceuticals
Jun 25, 2024
Maintains: Buy
Price Target: $1,060 → $1,170
Current: $746.46
Upside: +56.74%
Vertex Pharmaceuticals
Jun 17, 2024
Maintains: Buy
Price Target: $465 → $550
Current: $440.05
Upside: +24.99%
AstraZeneca
May 30, 2024
Maintains: Buy
Price Target: $80 → $85
Current: $202.24
Upside: -57.97%
Feb 1, 2024
Maintains: Buy
Price Target: $115 → $125
Current: $37.98
Upside: +229.12%
Sep 13, 2023
Maintains: Buy
Price Target: $160 → $140
Current: $50.68
Upside: +176.24%
Apr 5, 2023
Downgrades: Hold
Price Target: n/a
Current: $206.47
Upside: -
Jan 27, 2022
Downgrades: Hold
Price Target: n/a
Current: $31.15
Upside: -
Sep 10, 2021
Maintains: Buy
Price Target: $260 → $290
Current: $171.99
Upside: +68.61%
Jun 9, 2021
Upgrades: Buy
Price Target: $100
Current: $87.73
Upside: +13.99%
May 20, 2021
Maintains: Buy
Price Target: $270 → $295
Current: $264.18
Upside: +11.67%
May 5, 2021
Downgrades: Hold
Price Target: n/a
Current: $8.24
Upside: -
Oct 21, 2020
Upgrades: Buy
Price Target: $135
Current: $192.91
Upside: -30.02%
Apr 17, 2020
Downgrades: Hold
Price Target: n/a
Current: $11.31
Upside: -
Apr 6, 2020
Downgrades: Hold
Price Target: n/a
Current: $186.47
Upside: -
Mar 24, 2020
Downgrades: Hold
Price Target: n/a
Current: $213.44
Upside: -
Oct 30, 2019
Downgrades: Hold
Price Target: n/a
Current: $29.19
Upside: -
Nov 6, 2018
Maintains: Buy
Price Target: $150 → $155
Current: $497.42
Upside: -68.84%
Sep 19, 2018
Maintains: Buy
Price Target: $85 → $90
Current: $58.79
Upside: +53.09%